Peter Rehling

Prof. Dr. Peter Rehling is a Full Professor and Director of the Department of Cellular Biochemistry at the University Medical Center Göttingen. He serves as Acting Director of the Center of Biochemistry and Molecular Cell Biology and holds leadership roles in collaborative research initiatives like SFB1565 and SFB1190. His work focuses on mitochondrial protein biogenesis and its implications in disease.

• University of Freiburg: Assistant Professor (2004–2007), Research Group Leader (2000–2004)
• Ruhr University Bochum: Diploma in Biology and Chemistry (1987–1993)
• University of California San Diego: Postdoctoral Fellow (1998–2000) under S.D. Emr

Rehling's research explores mitochondrial protein import, OXPHOS complex assembly, and their role in metabolic disorders. His work bridges molecular mechanisms with clinical applications in cardiac and neurodegenerative diseases.

Recent publications emphasize mitochondrial translation dynamics, calcium signaling, and interorganelle communication. Articles highlight super-resolution imaging of mitochondrial mRNAs, kinases regulating translation, and disease-specific metabolic rewiring in cancer and cardiomyopathies.

• 2023 FEBS National Lecture Award
• 2022 ERC Advanced Investigator Grant 'MiXpress'
• 2022 EMBO Membership
• 2016 Copernicus Award (DFG/FNP)

Rehling has secured major grants through DFG (SFB1190, SFB860, FOR2848) and ERC projects, advancing mitochondrial research. His lab collaborates with institutions like the Polish Academy of Sciences and participates in clusters such as 'Multiscale Bioimaging.'